Background
Children and adolescents with perinatal HIV have a high risk of development of drug resistance mutations (DRM). Acquisition of DRM is related to non-adherence and frequent treatment switches in this vulnerable population. This study aimed to assess the cumulative prevalence of DRM in young adults with perinatal HIV compared to matched individuals with horizontally acquired HIV and to evaluate possible associated factors with the goal of contributing to treatment guidelines and long-term clinical care strategies in children and adolescents with HIV.
Methods
In this case-control study all Swiss Mother and Child HIV Cohort Study (MoCHiV) and Swiss HIV Cohort Study (SHCS) participants with perinatal HIV (cases) were included in the analysis after transfer to adult care and compared to matched SHCS participants with horizontally acquired HIV (controls). Only patients under antiretroviral treatment (ART) and with ≥1 available genotypic resistance test were included. The matching ratio was 1 case for 3 controls, and matching was based on sex, year of diagnosis and time since ART initiation. Demographic information, clinical characteristics and the prevalence of DRM were summarized by descriptive statistics. Negative-binomial regression was used for risk factor analysis.
Results
A total of 83 cases and 253 controls were included in the study. Thirty-five (43%) of the cases and 107 (42%) of the controls were male. Median time since ART initiation was 15.36 years (IQR 9.25-19.99) in cases and 14.92 years (IQR 8.76-18.73) in controls. DRM to ≥1 ART class were present in 51 (63%) cases and in 156 (62%) controls, with nucleoside reverse transcriptase inhibitor (NRTI) being the most affected class in both groups (58% vs 54.5%). Resistance to integrase strand transfer inhibitor (INSTI) was rare (1.2% vs 2.8%). DRM to 1, 2 and ≥3 ART classes were present in 22%, 27% and 14% of cases compared to 29%, 24.5% and 8% of controls, respectively. No statistically significant difference in the risk of DRM was found between cases and controls. Overall, time since ART initiation and ART start before 1997 were the only significant risk factors associated with the occurrence of DRM.
Conclusions
The cumulative prevalence of DRM was high in both individuals with perinatal HIV and with horizontally acquired HIV. Time since ART initiation and initial therapy in an era of less well tolerated ART regimens with lower resistance barriers, rather than perinatal HIV, were associated with a higher risk of DRM.